Literature DB >> 27252596

Retraction Note: Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans.

Guijuan Liu¹, Qiang Wu², Guilan Liu², Xueying Song³, Jihong Zhang².

Abstract

[This retracts the article DOI: 10.1186/s12935-014-0154-0.].

Entities: Disease Gene Species

Year: 2016 PMID： 27252596 PMCID： PMC4888407 DOI： 10.1186/s12935-016-0316-3

Source DB: PubMed Journal: Cancer Cell Int ISSN： 1475-2867 Impact factor: 5.722

Retraction to: Cancer Cell International (2015) 15:18 DOI 10.1186/s12935-014-0154-0

The editors are retracting this article [1] as it has been previously published in the International Journal of Clinical and Experimental Pathology [2] and it is therefore a redundant publication. The authors could not be reached by the journal for comment on the retraction.

2 in total

1. Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo.

Authors: Guijuan Liu; Qiang Wu; Guilan Liu; Xueying Song; Jihong Zhang
Journal: Int J Clin Exp Pathol Date: 2014-10-15

2. Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans.

Authors: Guijuan Liu; Qiang Wu; Guilan Liu; Xueying Song; Jihong Zhang
Journal: Cancer Cell Int Date: 2015-02-12 Impact factor: 5.722

2 in total